Cachexia is the involuntary loss of muscle and adipose tissue that strongly affects mortality
and treatment efficacy in patients with cancer or chronic inflammatory disease. Currently, no …

An awareness of the importance of nutritional status in hospital settings began more than 40
years ago. Much has been learned since and has altered care. For the past 40 years several …

Purpose Existing definitions of clinically important weight loss (WL) in patients with cancer
are unclear and heterogeneous and do not consider current trends toward obesity. Methods …

Oesophageal cancer is a debilitating disease with a poor prognosis, and weight loss owing
to malnutrition prevails in the majority of patients. Cachexia, a multifactorial syndrome …

Recent scientific advances have contributed much to the dissection of the complex
molecular and cellular pathways involved in the connection between cancer and …

Background Weight loss and cachexia are common, reduce tolerance of cancer treatment
and the likelihood of response, and independently predict poor outcome. Methods A group …

It is estimated that half of all patients with cancer eventually develop a syndrome of
cachexia, with anorexia and a progressive loss of adipose tissue and skeletal muscle mass …

About half of all cancer patients show a syndrome of cachexia, characterized by anorexia
and loss of adipose tissue and skeletal muscle mass. Cachexia can have a profound impact …

Cachexia is a wasting disorder that accompanies many chronic diseases including cancer
and results from an imbalance of energy requirements and energy uptake. In cancer …

Cachexia is a multifactorial process of skeletal muscle and adipose tissue atrophy resulting
in progressive weight loss. It is associated with poor quality of life, poor physical function …